In 2006 my father had a bladder cancer and he was getting the wrong chemotherapy and he was getting it a traditional high dose. I attended a medical meeting and met the owner of RGCC Group. He described a test where he could measure the amount of circulating cancer in the blood as well as determine which chemotherapy and which natural substances worked best. I performed the testing and found that my dad was getting ineffective chemotherapy. I switched to chemotherapy according to the test results and gave it to him in low doses, so he did not have side effects. He also received natural substances intravenously. Six months later my dad was cured of his cancer. Over the years I did intermittent blood testing and he remained negative. I periodically have testing and continue to be negative for cancer.

Research genetic cancer Center (RGCC) is a world class laboratory specializing in cancer genetics and circulating tumor counts. It focuses on molecular oncology. Every year the test panels are expanding and every year there are new vaccines now available for our cancer patients. The testing allows for early detection and diagnosis of new cancers, sometimes years before most cancers would be detected. It allows for the monitoring of the existing cancers as well as gives a prognosis concerning the recurrence of disease.

Additional testing includes chemosensitivity testing to identify which chemotherapy drug demonstrates the most effective to each individual patient. Testing is also performed to identify chemo resistance. This is the identification of chemotherapy drugs that will not be as effective for each individual patient.

Assessment of natural substances and plant extracts against each patient’s cancer is tested for. These natural substances are synergistic with the low dose chemotherapy.

I feel that immune function is very important in all patients but especially cancer patients. This is a test that I feel is necessary in each patient. Repairing immune function gives better outcomes and success.

In addition, the test evaluates 72 tumor related genes and for resistant factors that I use in formulating a personalized treatment plan.

Tumor free means that there are no active tumors that are found on ultrasound, x-ray, CAT scan, MRI, or PET scanning. In addition, or your blood markers are negative or within normal limits. Unfortunately, this is the term used in a large majority of cases. The patient is then told to watch and wait. If it comes back, then generally the patient is on palliative care or get another round of high-dose chemotherapy. This is sometimes accompanied with immunotherapy if indicated.

Cancer free includes everything from the tumor free plus there is no circulating cancer in your blood. The only normal level should be 0. I have monitored people over the years and the goal is to reach 0 and stay there. Maintaining a proactive approach is the key to success.

According to “Cancer growth metastasis” 2015 volume 8 metastasis frequently exists prior to the detection of the primary tumor. In addition, metastatic cells may reside in organs in the original host that are not usually the site of detectable secondary tumors. The problem is that metastatic cells can remain dormant for decades after the primary tumor has been removed. Adding to the problem is that dormancy might be reversible and lead to later recurrences. This being the problem it is important to obtain testing from RGCC on a periodic basis.

Personalized cancer treatment combining targeted low dose chemotherapy, natural substances, and immunotherapy worked best. We also used various vaccines including dendritic cell vaccine, whole tumor vaccine and SOT.

If you would like more information, please call us at the Silver cancer center to the learn more about our RGCC testing and personalized cancer care treatment programs. We can be reached at 727-330-3844.